Ebola Drug Shows Promise in Monkey Trial

February 10, 2015 7:00 PM

20 0

TUESDAY, Feb. 10, 2015 (HealthDay News) -- An investigational drug designed to stop Ebola in its tracks has shown early promise in a study involving rhesus monkeys, researchers say.

The drug in question, for now dubbed AVI-7537, appeared to safely protect 75 percent of treated monkeys from Ebola after exposure to the virus. However, it has not been tested in humans, and trials in animals often fail to translate to success in people, experts note.

Read more

To category page